About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT03624712

Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and thera...

Lead sponsor: University Hospital Tuebingen•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital Tuebingen

Collaborators

University Hospital Heidelberg
University of Homburg
University Hospital Freiburg

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma)
•If operable: surgical primary therapy: laparoscopic/robot-assisted or open radical gyneco-oncological surgery
•Written consent
•Willingness and ability to participate in all study-specific procedures
•Age ≥ 18 years

Exclusion Criteria

•Severe and acute general disease in the last 4 weeks
•Acute or chronic psychiatric disorders
•Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)

Related studies

Active Not RecruitingPhase 1

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT07038369 · Advanced Solid Tumors, Breast Cancer, and more

Active Not RecruitingPhase 2

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

NCT04579380 · Uterine Neoplasms, Uterine Cervical Neoplasms, and more

Not Yet Recruiting

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

NCT07382505 · Uterine Neoplasms, Cervical Cancer

Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial

NCT04679675 · Uterine Cervical Neoplasm, Uterine Neoplasms, and more

COMPLETEDPhase 1/2

Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide

NCT00188695 · Uterine Neoplasms, Cervix Neoplasms, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 17, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment580

Start dateJan 2012

Last updatedJan 17, 2025

Condition

Uterine Neoplasms

Locations shown

University Hospital Tuebingen, Department of Women's Health

Tübingen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 17, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions